|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 321.50 CHF | +0.66% |
|
+0.92% | -2.04% |
| 05-12 | Roche Receives CE Mark For Elecsys Ptau217 Blood Test For Alzheimer?S Disease Pathology | CI |
| 05-12 | Roche CEO Expects Pharma Portfolio to Deliver Sales Growth Through 2030 | DJ |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
| 862B | A | ||||||||
| 533B | BBB | ||||||||
| 358B | - | AA | - | - | |||||
| 286B | A | ||||||||
| 279B | AAA | ||||||||
| 275B | A | ||||||||
| 210B | A | ||||||||
| 178B | A | ||||||||
| 166B | AA | ||||||||
| 147B | A | ||||||||
| 114B | A | ||||||||
| 110B | AA | ||||||||
| 104B | AA | ||||||||
| 100B | AA | ||||||||
| 83.36B | AA | ||||||||
| 52.3B | AA | ||||||||
| 51.94B | AA | ||||||||
| 42.93B | AA | ||||||||
| 41.73B | - | ||||||||
| Average | 210.22B | AA | |||||||
| Weighted average by Cap. | AA |
- Stock Market
- Equities
- ROP Stock
- ROG Stock
- Sector Roche Holding AG
- Sector ratings
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















